medigraphic.com
ISSN 2448-5640 (Impreso)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2026, Número 3

<< Anterior Siguiente >>

Cir Card Mex 2026; 11 (3)


Sarcoma intimal cardíaco en aurícula derecha. Reporte de caso y revisión de la literatura

Rendón-Elías FG, Castillo-Romero C, Leyva-Villegas J, Salas-Ríos CM, Puentes U, Carranza-Hernández A, Gómez-Danés LH

Idioma: Ingles.
Referencias bibliográficas: 55
Paginas: 104-110
Archivo PDF: 1547.93 Kb.


RESUMEN

El sarcoma intimal cardíaco primario es un subtipo muy raro de tumor cardíaco, que a menudo se diagnostica erróneamente porque este tumor cardíaco puede presentarse de diversas maneras y se sabe que es un excelente imitador de otras afecciones. Debido a los avances en la inmunohistoquímica de los tumores cardíacos, el diagnóstico de sarcoma intimal cardíaco es cada vez más frecuente. Presentamos el caso de un paciente de 42 años, que se encontró con una masa auricular derecha durante el protocolo de disnea aguda en el servicio de urgencias, y tras una investigación adicional con tomografía computarizada mejorada confirmó la presencia de una masa auricular derecha que descarta el diagnóstico de mixoma o trombo cardíaco. El objetivo de este artículo es presentar el primer caso diagnosticado de sarcoma cardíaco intimal del corazón derecho en el país de los autores y proporcionar una revisión exhaustiva de la literatura médica sobre estos sarcomas cardíacos primarios raros, incluyendo detalles sobre su patogénesis, presentación clínica, tratamientos actuales, pronóstico y seguimiento.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Raphael KL, Martinez AP, Clements SD, Isiadinso I. Role of multimodal cardiac imaging in diagnosing a primary intimal sarcoma of the left atrial appendage. Tex Heart Inst J. 2019;46(1):28-31. doi: 10.14503/THIJ-16-5896.

  2. Moeri-Schimmel R, Pras E, Desar I, Krol S, Braam P. Primary sarcoma of the heart: case report and literature review. J Cardiothorac Surg. 2020;15(1):104. doi: 10.1186/s13019-020-01157-4.

  3. Thuraisingam A, Fletcher N, Mckay G. Primary cardiac intimal sarcoma. Ann Surg Case Rep. 2019;2(1):1013. doi: 10.1016/j.hlc.2019.02.113.

  4. Valecha G, Pau D, Nalluri N, Liu Y, Mohammad F, Atallah JP. Primary intimal sarcoma of the left atrium: an incidental finding on routine echocardiography. Rare Tumors. 2016;8(4):6389. doi: 10.4081/rt.2016.6389.

  5. Nomoto N, Tani T, Konda T, Kim K, Kitai T, Ota M, et al. Primary and metastatic cardiac tumors: echocardiographic diagnosis, treatment and prognosis in a 15-years single center study. J Cardiothorac Surg. 2017;12(1):103. doi: 10.1186/s13019-017-0672-7.

  6. Chitwood WR Jr. Clarence Crafoord and the first successful resection of a cardiac myxoma. Ann Thorac Surg. 1992;54(5):997-8. doi: 10.1016/0003-4975(92)90676-u.

  7. Patel J, Sheppard MN. Pathological study of primary cardiac and pericardial tumors in a specialist UK centre: surgical and autopsy series. Cardiovasc Pathol. 2010;19:343-352. doi: 10.1016/j.carpath.2009.07.005.

  8. Oliveira GH, Al-Kindi SG, Hoimes C, Park SJ. Characteristics and survival of malignant cardiac tumors: a 40-year analysis of > 500 patients. Circulation. 2015;132:2395-2402. doi: 10.1161/CIRCULATIONAHA.115.016418.

  9. International Agency for Research on Cancer, World Health Organization(WHO), International Academy of Pathology. WHO classification of tumours of the lung, plura, thymus and heart. 4a ed. Travis WD, editor. IARC; 2015.

  10. Maleszewski JJ, Basso C, Bois MC, Glass C, Klarich KW, Leduc C, et al. The 2021 WHO Classification of Tumors of the Heart. J Thorac Oncol. 2022;17(4):510-518. doi: 10.1016/j.jtho.2021.10.021.

  11. Thoracic tumours: WHO Classification of Tumors. WHO Classification of Tumours Editorial Board (editor). WHO editorial, 5th edition; 2021.

  12. Basso C, Valente M, Poletti A, Casarotto D, Thiene G. Surgical pathology of primary cardiac and pericardial tumors. Eur J Cardiothorac Surg. 1997;12:730-737. doi: 10.1016/s1010-7940(97)00246-7.

  13. Ekmektzoglou KA, Samelis GF, Xanthos T. Heart and tumors: location, metastasis, clinical manifestations, diagnostic approaches and therapeutic considerations. J Cardiovasc Med (Hagerstown). 2008;9:769-777. doi: 10.2459/JCM.0b013e3282f88e49.

  14. Simpson L, Kumar SK, Okuno SH, Schaff HV, Porrata LF, Buckner JC, et al. Malignant primary cardiac tumors: review of a single institution experience. Cancer. 2008;112(11):2440-2446. doi: 10.1002/cncr.23459.

  15. Bussani R, De-Giorgio F, Abbate A, Silvestri F. Cardiac metastases. J Clin Pathol. 2007;60:27-34. doi: 10.1136/jcp.2005.035105.

  16. Nistor C, Carsote M, Cucu AP, Stanciu M, Popa FL, Ciuche A, et al. Primary cardiac intimal sarcoma: multi-layered strategy and core role of MDM2 amplification/co-amplification and MDM2 immunostaining. Diagnostics (Basel). 2024;14(9):919. doi: 10.3390/diagnostics14090919.

  17. Ibrahim A, Luk A, Singhal P, Wan B, Zavodni A, Cusimano RJ, et al. Primary intimal (spindle cell) sarcoma of the heart: a case report and review of the literature. Case Rep Med 2013;2013:461815. doi: 10.1155/2013/461815.

  18. Butany J, Nair V, Naseemuddin A, Nair GM, Catton C, Yau T. Cardiac tumors: diagnosis and management. Lancet Oncol 2005;6:219-228. doi: 10.1016/S1470-2045(05)70093-0.

  19. Neuville A, Collin F, Bruneval P, Parrens M, Thivolet F, Gomez-Brouchet A, et al. Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas. Am J Surg Pathol 2014;38(4):461-469. doi: 10.1097/PAS.0000000000000184.

  20. Gupta A. Primary cardiac sarcomas. Expert Rev Cardiovasc Ther. 2008;6(10):1295-1297. doi: 10.1586/14779072.6.10.1295.

  21. Bruce C. 42-cardiac tumors. En: Otto CM, editor. The practice of clinical echocardiography. 5th ed. Elsevier; 2016.

  22. Kraft C, Schuettfort G, Weil Y, Tirneci V, Kasper A, Haberichter B, et al. Thrombosis of the inferior vena cava and malignant disease. Thromb Res. 2014;134(3):668-673. doi: 10.1016/j.thromres. 2014.07.012.

  23. Kojiro M, Nakahara H, Sugihara S, Murakami T, Nakashima T, Kawasaki H. Hepatocellular carcinoma with intra-atrial tumor growth. A clinicopathologic study of 18 autopsy cases. Arch Pathol Lab Med. 1984;108(12):989-992. doi: 10.1007/978-4-431-68177-9_4.

  24. Wang Y, Yuan L, Ge RL, Sun Y, Wei G. Survival benefit of surgical treatment for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: results of a retrospective cohort study. Ann Surg Oncol. 2013;20(3):914-922. doi: 10.1245/s10434-012-2756-0.

  25. Wassef J, Xu S. Hepatocellular carcinoma with tumor thrombus to the hepatic veins and the right atrium: a case report and review exploring various presentations and treatment options. Cureus. 2020;12(6):e8405. doi: 10.7759/cureus.8405.

  26. Lee JM, Lee KW, Hong SK, Yoon KC, Cho JH, Yi NJ, et al. Unusual techniques for preserving surgical and oncologic safety in hepatectomy of advanced adrenal malignancy with vena cava and liver invasion. Ann Surg Oncol. 2018;25(11):3324-3325. doi: 10.1245/s10434-018-6545-3.

  27. Sun N, Zhang J, Li B, Li A, Lv M, Zhang C. Favorable response to multimodal treatment in hepatocellular carcinoma with inferior vena cava and right atrial tumor thrombus and left adrenal gland metastasis: a case report and literature review. Medicine (Baltimore). 2021;100(49):e27987. doi: 10.1097/MD.0000000000027987.

  28. Lestuzzi C. Primary tumors of the heart. Curr Opin Cardiol. 2016;31(6):593-598. doi: 10.1097/HCO.0000000000000335.

  29. Tyebally S, Chen D, Bhattacharyya S, Mughrabi A, Hussain Z, Manisty C, et al. Cardiac tumors: JACC CardioOncology state-of-the-art review. JACC CardioOncol. 2020;2(2):293-311. doi: 10.1016/j.jaccao.2020.05.009.

  30. Buckley O, Madan R, Kwong R, Rybicki FJ, Hunsaker A. Cardiac masses, part 1: imaging strategies and technical considerations. AJR Am J Roentgenol 2011;197(5):W837-W841. doi: 10.2214/AJR.10.7260.

  31. Zaragosa-Macias E, Chen MA, Gill EA. Real time three-dimensional echocardiography evaluation of intracardiac masses. Echocardiography. 2012;29(2):207-219. doi: 10.1111/j.1540-8175.2011.01627.x.

  32. Bhattacharyya S, Khattar R, Senior R. Characterisation of intra-cardiac masses by myocardial contrast echocardiography. Int J Cardiol. 2013;163(1):e11-e13. doi: 10.1016/j.ijcard.2012.06.098.

  33. Kirkpatrick JN, Wong T, Bednarz JE, Spencer KT, Sugeng L, Ward RP, et al. Differential diagnosis of cardiac masses using contrast echocardiographic perfusion imaging. J Am Coll Cardiol. 2004;43(8):1412-1419. doi: 10.1016/j.jacc.2003.09.065.

  34. Beroukhim RS, Prakash A, Buechel ER, Cava JR, Dorfman AL, Festa P, et al. Characterization of cardiac tumors in children by cardiovascular magnetic resonance imaging: a multicenter experience. J Am Coll Cardiol. 2011;58810):1044-1054. doi: 10.1016/j.jacc.2011.05.027.

  35. Kassop D, Donovan MS, Cheezum MK, et al. Cardiac masses on cardiac CT: a review. Curr Cardiovasc Imaging Rep. 2014;7(8):9281. doi: 10.1007/s12410-014-9281-1.

  36. Alama L, Agrawala K, Kankanala K, Fishberg R, Powell D. Primary cardiac undifferentiated high-grade intimal pleomorphic sarcoma: a case series report. Cardiol Res. 2020;11(2):129-133. doi: 10.14740/cr1029.

  37. Tamaki T, Suzuki M, Umezu R, Utanohara Y, Mahara K, Takanashi S, et al. Clinicopathological features of bi-ventricular cardiac intimal sarcoma-Report of an autopsy case. J Cardiol Cases. 2017;16(4):113-115. doi: 10.1016/j.jccase.2017.06.001.

  38. Hudzik B, Szkodzinski J, Zubelewicz-Skodzinska B, Gasior M. Primary sarcoma of the heart. Pol Arch Intern Med. 2017;127(10):694-695. doi: 10.20452/pamw.4121.

  39. Lennerz C, O'Connor M, Schunkert H, Deutsch MA. A case report of primary cardiac sarcoma: A diagnostic and therapeutic challenge. Eur Heart J Case Rep. 2018;2(4):1-4. doi: 10.1093/ehjcr/yty143.

  40. Beller JP, Maddalo S, Zamuco R, Axel L, DeAnda A, Balsam LB. Right ventricular undifferentiated pleomorphic sarcoma: a case report. J Cardiol Cases. 2015;13(2):60-62. doi: 10.1016/j.jccase.2015.10.008.

  41. Muturi A, Kotecha V, Ruturi J, Muhinga M, Waweru W. High-grade spindle cell sarcoma of the heart: a case report and review of literature. J Cardiothorac Surg. 2015;29(10):46. doi: 10.1186/s13019-015-0245-6.

  42. Mito JK, Mitra D, Doyle LA. Radiation-associated sarcomas: an update on clinical, histologic, and molecular features. Surg Pathol Clin. 2019;12(1):139-148. doi: 10.1016/j.path.2018.10.010.

  43. Chen E. Pathogenesis of sarcomas. Diagn Pathol. 2016;01(01). doi: 10.4172/2476-2024.1000e103.

  44. Salminen SH, Sampo MM, Bohling TO, Tuomikoski L, Tarkkanen M, Blomqvist CP. Radiation-associated sarcoma after breast cancer in a nationwide population: increasing risk of angiosarcoma. Cancer Med. 2018;7(9):4825-4835. doi: 10.1002/cam4.1698.

  45. Orlandi A, Ferlosio A, Roselli M, Chiariello L, Spagnoli LG. Cardiac sarcomas: an update. J Thorac Oncol. 2010;5(9):1483-1489. doi: 10.1097/JTO.0b013e3181e59a91.

  46. Burke AP, Cowan D, Virmani R. Primary sarcomas of the heart. Cancer. 1992;69(2):387-395. doi: 10.1002/1097-0142(19920115)69:2<387:aid-cncr2820690219>3.0.co;2n.

  47. Ye N, Lan L, Hu H, Liu J, Xu H. Case report: The diagnostic challenge of primary cardiac intimal sarcoma. Front Cardiovasc Med. 2023;10. doi: 10.3389/fcvm.2023.1089636.

  48. Blackmon SH, Patel A, Reardon MJ. Management of primary cardiac sarcomas. Expert Rev Cardiovasc Ther. 2008;6(9):1217-22. doi: 10.1586/14779072.6.9.1217.

  49. Modi A, Lipnevicius A, Moorjani N, Haw M. Prolonged survival with left atrial spindle cell sarcoma. Interact Cardiovasc Thorac Surg. 2009;8(6):703-704. doi: 10.1510/icvts.2009.203562.

  50. Fu B, Yu H, Yang J. Primary intimal (spindle cell) sarcoma of the left atrium. Echocardiography. 2015;32(1):192-4. doi: 10.1111/echo.12777.

  51. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma meta-analysis collaboration. Lancet. 1997;350(9092):1647-1654.

  52. Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M. et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 2008;113:573-581. doi: 10.1002/cncr.23592.

  53. Maki RG, Wathen JK, Patel SR, Priebat DA, Okuno SH, Samuels B, et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002. J Clin Oncol. 2007;25(19):2755-2763. doi: 10.1200/JCO.2006.10.4117.

  54. Pautier P, Floquet A, Penel N, et al. Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study). Oncologist 2012;17(9):1213-1220. doi: 10.1634/theoncologist.2011-0467.

  55. Van der Graaf WT, Blay JY, Chawla SP, Kim DW, Bui-Nguyen B, Casali PG, et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double- blind, placebo-controlled phase 3 trial. Lancet. 2012;379(9829):1879-1886. doi: 10.1016/S0140-6736(12)60651-5.




2020     |     www.medigraphic.com